Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FAWJK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,033
Award facts
- Contract value 100% obligated
- $12,033.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,033.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 9, 2025. The delivery order calls for the supply of Trelegy Ellipta 100-62.5-25 (60 count), a prescription inhalation medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order is set to be completed by September 10, 2025, with the place of performance in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing in federal procurement despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, supporting the medical supply needs of military healthcare facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides critical distribution of prescription medications and pharmacy services directly to Department of Defense healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FAWJK?
SPE2DB25FAWJK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FAWJK worth?
The government has obligated $12,033 on SPE2DB25FAWJK.
Is contract SPE2DB25FAWJK an order under another contract?
Yes. SPE2DB25FAWJK is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWJK competed?
The extent of competition for SPE2DB25FAWJK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award